2.71
price down icon2.17%   -0.06
after-market アフターアワーズ: 2.71
loading
前日終値:
$2.77
開ける:
$2.76
24時間の取引高:
2.62M
Relative Volume:
0.70
時価総額:
$718.54M
収益:
$194.75M
当期純損益:
$-51.26M
株価収益率:
-9.6786
EPS:
-0.28
ネットキャッシュフロー:
$-23.38M
1週間 パフォーマンス:
-8.45%
1か月 パフォーマンス:
-10.56%
6か月 パフォーマンス:
+38.97%
1年 パフォーマンス:
+105.30%
1日の値動き範囲:
Value
$2.69
$2.7799
1週間の範囲:
Value
$2.69
$2.98
52週間の値動き範囲:
Value
$1.24
$4.0787

Akebia Therapeutics Inc Stock (AKBA) Company Profile

Name
名前
Akebia Therapeutics Inc
Name
セクター
Healthcare (1143)
Name
電話
617-871-2098
Name
住所
245 FIRST STREET, CAMBRIDGE, MA
Name
職員
181
Name
Twitter
@akebiatx
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
AKBA's Discussions on Twitter

AKBA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
AKBA
Akebia Therapeutics Inc
2.71 734.45M 194.75M -51.26M -23.38M -0.28
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.13 62.79B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.65 47.25B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
8.72 39.56B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.36 22.11B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
425.42 19.84B 2.99B 1.21B 1.13B 25.06

Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-04 再開されました H.C. Wainwright Buy
2025-04-28 開始されました Leerink Partners Outperform
2025-04-01 開始されました Jefferies Buy
2023-11-29 再開されました BTIG Research Buy
2023-08-28 アップグレード H.C. Wainwright Neutral → Buy
2023-05-31 アップグレード Piper Sandler Neutral → Overweight
2022-03-31 ダウングレード H.C. Wainwright Buy → Neutral
2022-03-31 ダウングレード Mizuho Buy → Neutral
2022-03-31 ダウングレード Needham Buy → Hold
2022-03-31 ダウングレード Piper Sandler Overweight → Neutral
2021-03-08 開始されました Cantor Fitzgerald Overweight
2021-01-29 ダウングレード JP Morgan Neutral → Underweight
2019-11-14 繰り返されました Needham Buy
2019-08-06 繰り返されました H.C. Wainwright Buy
2019-07-11 繰り返されました H.C. Wainwright Buy
2019-05-02 開始されました JP Morgan Overweight
2019-03-20 開始されました Citigroup Neutral
2018-09-07 再開されました Morgan Stanley Equal-Weight
2018-08-10 繰り返されました Needham Buy
2018-06-06 繰り返されました H.C. Wainwright Buy
2017-12-19 開始されました Piper Jaffray Overweight
2017-12-07 開始されました BTIG Research Buy
2017-09-15 開始されました RBC Capital Mkts Sector Perform
2017-07-10 繰り返されました H.C. Wainwright Buy
2017-04-27 繰り返されました H.C. Wainwright Buy
2017-04-27 繰り返されました Needham Buy
2016-12-27 繰り返されました H.C. Wainwright Buy
2016-12-20 繰り返されました JMP Securities Mkt Outperform
2016-11-15 開始されました Aegis Capital Buy
2016-09-29 開始されました Brean Capital Buy
2016-03-16 繰り返されました Needham Buy
2016-01-21 開始されました Credit Suisse Neutral
すべてを表示

Akebia Therapeutics Inc (AKBA) 最新ニュース

pulisher
Sep 24, 2025

Karyopharm Therapeutics (KPTI) Moves 27.9% Higher: Will This Strength Last? - Yahoo Finance

Sep 24, 2025
pulisher
Sep 20, 2025

Goldman Sachs Group Inc. Grows Stock Holdings in Akebia Therapeutics, Inc. $AKBA - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Market Review: Should value investors consider NRGD2025 Top Decliners & Fast Exit/Entry Strategy Plans - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Options Flow: Can VIVS navigate macro headwindsMarket Performance Report & Technical Analysis for Trade Confirmation - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Akebia Therapeutics extends loan agreement, receives $9.3M - MSN

Sep 20, 2025
pulisher
Sep 20, 2025

Can Akebia Therapeutics Inc benefit from deglobalization2025 Biggest Moves & Risk Controlled Stock Pick Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Aug Ideas: Is Akebia Therapeutics Inc attractive for institutional investorsEarnings Recap Report & Free Weekly Chart Analysis and Trade Guides - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Akebia Therapeutics (NASDAQ:AKBA) Downgraded by Wall Street Zen to "Buy" - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Options Flow: Does Akebia Therapeutics Inc have strong fundamentalsMarket Performance Report & Consistent Income Trade Recommendations - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Volume Report: What is Akebia Therapeutics Inc. s 5 year growth outlookMarket Sentiment Summary & High Conviction Investment Ideas - خودرو بانک

Sep 18, 2025
pulisher
Sep 16, 2025

Trade Recap: Is Akebia Therapeutics Inc stock forming a cup and handleWeekly Trend Summary & Precise Trade Entry Recommendations - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Woodline Partners LP Buys New Stake in Akebia Therapeutics, Inc. $AKBA - MarketBeat

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Outlook: Is Akebia Therapeutics Incs ROIC above industry averageInsider Buying & Real-Time Stock Entry Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Summary: Is Akebia Therapeutics Inc stock trending bullishWeekly Stock Report & Risk Controlled Daily Plans - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Jobs Data: Is Akebia Therapeutics Inc forming a double bottomJuly 2025 Volume & Real-Time Market Sentiment Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Exit Recap: Can Akebia Therapeutics Inc deliver consistent EPS growthPrice Action & Expert-Curated Trade Recommendations - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Analyst Upgrade: Whats the beta of Akebia Therapeutics Inc stock2025 Major Catalysts & Weekly Top Gainers Trade List - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Quarterly Earnings: Does ProShares Trust ProShares UltraShort Russell2000 have declining or rising EPSJuly 2025 Chart Watch & AI Based Trade Execution Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

What is Akebia Therapeutics Inc. s 5 year growth outlookJuly 2025 Institutional & Stepwise Trade Execution Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Weekly Trades: What is Fidelity National Financial Incs valuation compared to sectorShort Setup & Long-Term Safe Investment Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Market Leaders: Can Akebia Therapeutics Inc stock outperform in a bear market2025 Sector Review & Fast Exit and Entry Strategy Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Whats the beta of Akebia Therapeutics Inc stockJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Entry Recap: Is Akebia Therapeutics Inc a stock for growth or value investorsMarket Risk Summary & Fast Entry and Exit Trade Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Winners Losers: Is Akebia Therapeutics Inc. a strong candidate for buy and holdInflation Watch & Weekly High Return Forecasts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Jacobs Levy Equity Management Inc. Has $3.03 Million Stake in Akebia Therapeutics, Inc. $AKBA - MarketBeat

Sep 15, 2025
pulisher
Sep 12, 2025

134,277 Shares in Akebia Therapeutics, Inc. $AKBA Purchased by Alyeska Investment Group L.P. - MarketBeat

Sep 12, 2025
pulisher
Sep 11, 2025

Invesco Ltd. Purchases 139,957 Shares of Akebia Therapeutics, Inc. $AKBA - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Individual Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Market Cap Dropped by US$50m - 富途牛牛

Sep 11, 2025
pulisher
Sep 11, 2025

Retail investors who have a significant stake must be disappointed along with institutions after Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) market cap dropped by US$50m - simplywall.st

Sep 11, 2025
pulisher
Sep 10, 2025

MetLife Investment Management LLC Buys 14,134 Shares of Akebia Therapeutics, Inc. $AKBA - Defense World

Sep 10, 2025
pulisher
Sep 08, 2025

Akebia at H.C. Wainwright: Strategic Growth in Anemia Treatment By Investing.com - Investing.com Canada

Sep 08, 2025
pulisher
Sep 08, 2025

Akebia at H.C. Wainwright: Strategic Growth in Anemia Treatment - Investing.com

Sep 08, 2025
pulisher
Sep 08, 2025

Akebia Therapeutics Inc. Stock Poised for Technical ComebackWeekly Investment Recap & Free Expert Approved Momentum Trade Ideas - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Akebia outlines access to over 275,000 dialysis patients for Vafseo in Q4 as DaVita pilot launches - MSN

Sep 08, 2025
pulisher
Sep 08, 2025

Does Akebia Therapeutics Inc. have pricing powerJuly 2025 Movers & High Accuracy Investment Entry Signals - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

What are Akebia Therapeutics Inc.’s earnings expectationsMarket Volume Report & Consistent Income Trade Ideas - 뉴스영

Sep 08, 2025
pulisher
Sep 07, 2025

Akebia Therapeutics (AKBA) Grants Stock Options to New Employees - MSN

Sep 07, 2025
pulisher
Sep 06, 2025

Nantahala Capital Management LLC Invests $3.84 Million in Akebia Therapeutics, Inc. $AKBA - MarketBeat

Sep 06, 2025
pulisher
Sep 06, 2025

Akebia Therapeutics, Inc. (NASDAQ:AKBA) most popular amongst individual investors who own 55% of the shares, institutions hold 43% - Yahoo Finance

Sep 06, 2025
pulisher
Sep 06, 2025

Invesco Ltd. Acquires 139,957 Shares of Akebia Therapeutics, Inc. $AKBA - Defense World

Sep 06, 2025
pulisher
Sep 06, 2025

How to interpret RSI for Akebia Therapeutics Inc. stockPortfolio Return Report & AI Enhanced Execution Alerts - Newser

Sep 06, 2025
pulisher
Sep 05, 2025

Panic Selling: Is Akebia Therapeutics Inc. forming a bullish divergencePortfolio Gains Summary & Daily Stock Trend Watchlist - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Can Akebia Therapeutics Inc. keep up with sector leadersTrade Analysis Summary & Scalable Portfolio Growth Methods - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Is Akebia Therapeutics Inc. a strong candidate for buy and holdJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka - TheStreet

Sep 05, 2025
pulisher
Sep 05, 2025

Detecting support and resistance levels for Akebia Therapeutics Inc.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Measuring Akebia Therapeutics Inc.’s beta against major indicesPortfolio Performance Summary & High Accuracy Buy Signal Tips - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Wellington Management Group LLP Acquires 164,440 Shares of Akebia Therapeutics, Inc. $AKBA - MarketBeat

Sep 05, 2025

Akebia Therapeutics Inc (AKBA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.92
price up icon 0.91%
$9.49
price down icon 2.27%
drug_manufacturers_specialty_generic RDY
$14.16
price down icon 1.94%
$54.87
price up icon 3.04%
$140.89
price down icon 3.94%
$425.42
price down icon 3.04%
大文字化:     |  ボリューム (24 時間):